Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Stock Chart & Stats
$4.98
-$0.30(-3.00%)
At close: 4:00 PM EST
$4.98
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$4.70 - $15.21
Previous CloseN/A
Volume1.13M
Average Volume (3M)6.39M
Market Cap
$889.14M
Enterprise Value$1.20B
Total Cash (Recent Filing)$726.25M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)―
Beta1.42
Next Earnings
Feb 25, 2026EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.28
Shares Outstanding177,473,400
10 Day Avg. Volume8,323,070
30 Day Avg. Volume6,389,290
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)1.04
Price to Sales (P/S)0.60
P/FCF Ratio5.48
Enterprise Value/Market Cap1.35
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit0.68
Enterprise Value/Ebitda-40.49
Forecast
1Y Price Target
$8.07Price Target Upside62.05% Upside
Rating ConsensusHold
Number of Analyst Covering8
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Care ProfitabilityIntegrated Care's differentiated offering and recent outperformance on adjusted EBITDA with strong margins could strengthen investor confidence in segment-level profitability.
International Expansion And MonetizationManagement initiatives to expand internationally and increasingly monetize the existing member base could unlock incremental revenue from the company's broad member network.
Livongo User GrowthRobust Livongo user growth, supported by a large weight-management contract win, could drive renewed revenue momentum as monthly active user totals rise.
Bears Say
BetterHelp User DeclineSustained declines in BetterHelp monthly active users, particularly internationally, indicate weakness in the direct-to-consumer channel and pose downside risk to revenue stability.
Competition And Margin PressureA post-pandemic growth stall combined with intensifying competition from peers and planned investments for future growth could compress margins and limit valuation recovery.
Revenue VisibilityThird-party app-tracking data that trends below consensus and diverges from management commentary raises uncertainty around near-term revenue estimates and guidance reliability.
Teladoc News
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $4.70 and its highest was $15.21 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $889.14M.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Feb 25, 2026 which is in 14 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Oct 29, 2025. The company reported -$0.28 earnings per share for the quarter, missing the consensus estimate of -$0.264 by -$0.016.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.18.
How many shares outstanding does Teladoc have?
Teladoc has 177,473,400 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.28 in its last earnings report, missing expectations of -$0.264. Following the earnings report the stock price went up 6.197%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.07 (62.05% Upside)
$8.07 (62.05% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 60%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 3.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 5.6%
Last 30 Days ▼ 5.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-61.54%
12-Months-Change
Fundamentals
Return on Equity
-15.42%
Trailing 12-Months
Asset Growth
-18.42%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Teladoc Health showed resilience with revenue and EBITDA exceeding guidance midpoints, strong international growth, and mental health expansion. However, challenges in BetterHelp's U.S. cash pay segment and a goodwill impairment charge weigh on the outlook.View all TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$8.07
▲(62.05% Upside)
Technical Analysis
Ownership Overview
0.48% Insiders
21.28% Mutual Funds
0.02% Other Institutional Investors
58.83% Public Companies and Individual Investors